Sickle cell disease (SCD) affects millions globally, causing debilitating pain, organ damage, and shortened lifespans. Traditional treatments offer relief, but a cure remains elusive. Enter gene therapy, a promising approach aiming to correct the faulty gene and offer a permanent solution. But here’s the exciting part: artificial intelligence (AI) is emerging as a game-changer in this fight. Beyond the Lab: AI…